Academic Rank:
Affiliated with James Hogg Research Centre and Institute for Heart + Lung Health
Vancouver General Hospital

Andrew Churg is Professor of Pathology at the University of British Columbia in Vancouver, BC. He obtained his PhD and MD from the University of Chicago, and did a fellowship in lung pathology with Charles Carrington at Stanford University. His laboratory has long focused on the effects of occupational and environmental agents on the lung. In addition he has major interests in the diagnosis of malignant mesothelioma and interstitial lung disease.

For many years he studied the relationship between asbestos fiber burden and disease, and the interactions of exogenous oxidants and particles in the lung. His current basic research efforts are devoted to chronic obstructive lung disease and encompass two areas:

  1. the factors that control small airway remodeling, both that induced by cigarette smoke and that induced by air pollution particles and occupationally encountered dusts;
  2. models of cigarette smoke-induced emphysema in laboratory animals.

In the diagnostic arena, he is the senior author of the 4th Series Fascicle: Tumors of the Serosal Membranes, senior editor of Thurlbeck’s Pathology of the Lung, 3rd Edition, and has published extensively in various areas of diagnostic lung pathology. He is the course director for two CME courses sponsored by the American Society for Clinical Pathology:  Update in Pulmonary Pathology, and Update in Surgical Pathology.

Academic background

  • AB, Columbia University, NY, Chemistry. 1967
  • PhD, University of Chicago, Pathology. 1971
  • MD, University of Chicago, Medicine. 1973
  • Postdoctoral Fellowship, Pulmonary Pathology, Stanford University. 1977-1978
  • Internship and Residency, Pathology, University of Chicago. 1973-1977


  • Sheffield BS, Hwang HC, Lee AF, Thompson K, Rodriguez S, Tse CH, Gown Am, Churg A. BAPI immunohistochemistry and p16 FISH to separate benign form malignant mesothelial proliferation. AM J Surg Pathol, in press 2015.
  • Dvorak LA, Vassallo R, Kirmani S, Johnson G, Hartman TE, Tazelaaz HD, Leslie KO, Colby TV, Cockcroft DW, Churg AM, Yi ES. Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases. Hum Pathol. 2015 in press.
  • English C, Churg A, Lam S, Bilawich AM. Respiratory bronchiolitis with fibrosis: prevalence and progression. Ann Amer Thro Soc 2014; 11:1665-1666.
  • Hwang H, Tse C, Rodriguez S, Gown A, Churg A. p16 FISH Deletion in Surface Epithelial Mesothelial Proliferations Is Predictive of Underlying Invasive Mesothelioma. Am J Surg Pathol. 2014;38:681-688.
  • Churg A, Allen T, Borczuk AC, Cagle PT, Galateau-Sallé F, Hwang H, Murer B, Murty VV,   Ordonez N, Tazelaar HD, Wick M. Well-differentiated papillary mesothelioma with invasive foci. Am J Surg Pathol. 2014; 38:990-998.
  • Churg A, Hall R, Bilawich AM. Respiratory bronchiolitis with fibrosis – interstitial lung disease. A new form of smoking-related interstitial lung disease. Arch Path Lab Med, in press. 2014
  • Bilawich AM, Churg A. Diagnosing organizing pneumonia: Limitations of radiology and pathology. Rev Clin Esp. 2014; 214: 256-257.
  • Hackett TL, Shaheen F, Zhou S, Wright JL, Churg A. Fibroblast STAT-4 drives cigarette smoke-induced airway fibrosis. Am J Respir Cell Mol Biol. 2014 Jun 12. [Epub ahead of print] PubMed PMID: 24922586.
  • Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson A, Roggli V, Travis WD, Wick M. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013; 137:647-667.
  • Zhou S, Wright JL, Liu J, Sin DD, Churg A: Aging does not enhance experimental COPD in the mouse. PloS One 2013; 8:e71410.

Research Interest

  • Pathology of occupational lung disease: diagnosis and mechanisms
  • Cardiovascular & Pulmonary disease